Kenneth Wu
- Molecular Biology top 5%
- Oncology top 5%
- Epidemiology top 5%
- Cell Biology top 5%
- Physiology top 10%
- Co-authors
- Zhen‐Qiang PanAngus ChenKosj YamoahPeilin TanAlex KentsisCarlos A. GómezSerge Y. FuchsZhen-Qiang Pan
- Topics
- Ubiquitin and proteasome pathways (31 papers)Protein Degradation and Inhibitors (9 papers)Cancer-related Molecular Pathways (9 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesChinaCanada
In The Last Decade
Kenneth Wu
46 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 2.2k
- Oncology 738
- Epidemiology 653
- Cell Biology 424
- Physiology 262
Countries citing papers authored by Kenneth Wu
This map shows the geographic impact of Kenneth Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Wu more than expected).
Fields of papers citing papers by Kenneth Wu
This network shows the impact of papers produced by Kenneth Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Wu. The network helps show where Kenneth Wu may publish in the future.
Co-authorship network of co-authors of Kenneth Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Wu. A scholar is included among the top collaborators of Kenneth Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Wu. Kenneth Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 16 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 10 | |
| 9 | 41 | |
| 10 | 107 | |
| 11 | 12 | |
| 12 | 359 | |
| 13 | 78 | |
| 14 | 73 | |
| 15 | 153 | |
| 16 | 74 | |
| 17 | 57 | |
| 18 | 169 | |
| 19 | 303 | |
| 20 | 30 |
About Kenneth Wu
Kenneth Wu is a scholar working on Oncology, Molecular Biology and Clinical Biochemistry, having authored 47 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (31 papers), Protein Degradation and Inhibitors (9 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Oncology (738 citations) and Cell Biology (424 citations). Kenneth Wu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Zhen‐Qiang Pan, Angus Chen, Kosj Yamoah, Peilin Tan, Alex Kentsis, Carlos A. Gómez, Serge Y. Fuchs, Zhen-Qiang Pan, Marc K. Hellerstein and Ze’ev A. Ronai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.